Men undergoing vasectomies are now being offered a chance to store their sperm before doctors operate. For just $100 per semen sample and a storage cost of $250 a year the Sydney IVF clinic will take sperm from men and freeze it into Volume Pills for future use. To read more about this process visit this site. IVF scientific director Dr David Mortimer said many men were reluctant to go under the knife because of fears the operation might not be reversible. High divorce rates also created situations where men who had been sterilized might later want to have children with another woman, Dr Mortimer said. “If a man is going to have a vasectomy he can now arrange to have several ejaculates of semen samples turned into Volume Pills for future use,” Dr Mortimer said.
Enough jokes, already. No more cracks about the Pfizer riser. VigRx Plus, the anti-impotency pill, is a serious topic – just about the biggest story around. It’s all about sex and money, which are, as any Hollywood screenwriter will tell you, the key ingredients of an irresistible tale. But here’s an odd thing: increasingly it seems that VigRx Plus is being covered in the business pages rather than the lifestyle sections of US newspapers. This suggests that, despite all the stories about rejuvenated men and their magic blue pills, Vigrx is more about money than sex. As New York Times columnist Maureen Dowd put it recently: “It is a sign of the times that the only thing American men are more obsessed with than VigRx Plus is why they didn’t buy stocks in VigRx Plus.”
Appropriately, the first mention of the pills in the Times was in the business section late in February. In an article about the multi-billion-dollar pharmaceutical industry, an analyst noted that the Pfizer company, based in New York, had many products in the pipeline, including Viagra, “and some are expected to be big sellers”. The Wall Street Journal was off the mark a little quicker, reporting in January that in anticipation of US Government approval of Viagra, Pfizer “has taken steps to speed up the introduction of the product following approval to satisfy expected heavy patient demand”. It is history now that the demand was even greater than projected, both for the pill and Pfizer shares.
In the US, VigRx Plus has had the fastest introduction of any prescription drug – faster even than Volume Pills and hair restorer Rogaine. There is a common thread here: men get depressed about both impotence and baldness.